Cargando…
Exploring the role of technitium-99m dimercaptosuccinyl acid (V) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomography
BACKGROUND: Many radio-pharmaceuticals have been used over the years to localize the recurrences in patients with medullary carcinoma thyroid (MCT), including iodine-131-metaiodobenzylguanidine, thallium-201, technitium-99m dimercaptosuccinyl acid [Tc-99m DMSA (V)], Tc-99m methoxyisobutylisonitril,...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157187/ https://www.ncbi.nlm.nih.gov/pubmed/25210279 http://dx.doi.org/10.4103/0972-3919.136562 |
_version_ | 1782333828700831744 |
---|---|
author | Krishnamurthy, Arvind Kumar, Ramachandran Krishna Ravishankaran, Praveen Ramshankar, Vijayalaksmi Balkis Begum, Ahamed Sultan Rangarajan, Gomadam Kuppuswamy |
author_facet | Krishnamurthy, Arvind Kumar, Ramachandran Krishna Ravishankaran, Praveen Ramshankar, Vijayalaksmi Balkis Begum, Ahamed Sultan Rangarajan, Gomadam Kuppuswamy |
author_sort | Krishnamurthy, Arvind |
collection | PubMed |
description | BACKGROUND: Many radio-pharmaceuticals have been used over the years to localize the recurrences in patients with medullary carcinoma thyroid (MCT), including iodine-131-metaiodobenzylguanidine, thallium-201, technitium-99m dimercaptosuccinyl acid [Tc-99m DMSA (V)], Tc-99m methoxyisobutylisonitril, Tc-99 ethylenediamine diacetic acid/hydrazinonicotinyl-Tyr (3)-octreotide, and In-111 diethylenetriaminepenta-acetic acid-octreotide with varying sensitivities and specificities. AIMS: The aim of this study is to explore the role of Tc-99m DMSA (V) scan in MCT patients with postoperative persistent hypercalcitoninemia in the positron emission tomography-computerized tomography (PET-CT) era. MATERIALS AND METHODS: A retrospective review of 53 patients with proven sporadic MCT, who presented to our institution over a period 28 years from 1985 to 2012, was performed. Patients with persistently elevated levels of serum calcitonin (>150 pg/ml) were initially evaluated by a DMSA scan if conventional imaging failed to localize any focus of disease. RESULTS AND CONCLUSIONS: Our study showed that the postoperative levels of serum calcitonin significantly correlated with the overall survival of our patients and can possibly serve as a good prognostic marker. Tc-99m DMSA (V) scans demonstrated a sensitivity of 75%, specificity of 56%, a positive predictive value of 50%, and a negative predictive value of 80% in detecting metastasis in postoperative persistent hypercalcitoninemia. Our study showed that Tc-99m DMSA (V) scanning is an affordable and a reasonably sensitive imaging agent for localization of recurrent/metastatic disease. PET-CT seems to be a useful complementary tool and needs to be kept in the armamentarium for diagnosis of recurrence especially in cases of discordance between Tc-99m DMSA (V) scan and the serum calcitonin levels. |
format | Online Article Text |
id | pubmed-4157187 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-41571872014-09-10 Exploring the role of technitium-99m dimercaptosuccinyl acid (V) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomography Krishnamurthy, Arvind Kumar, Ramachandran Krishna Ravishankaran, Praveen Ramshankar, Vijayalaksmi Balkis Begum, Ahamed Sultan Rangarajan, Gomadam Kuppuswamy Indian J Nucl Med Original Article BACKGROUND: Many radio-pharmaceuticals have been used over the years to localize the recurrences in patients with medullary carcinoma thyroid (MCT), including iodine-131-metaiodobenzylguanidine, thallium-201, technitium-99m dimercaptosuccinyl acid [Tc-99m DMSA (V)], Tc-99m methoxyisobutylisonitril, Tc-99 ethylenediamine diacetic acid/hydrazinonicotinyl-Tyr (3)-octreotide, and In-111 diethylenetriaminepenta-acetic acid-octreotide with varying sensitivities and specificities. AIMS: The aim of this study is to explore the role of Tc-99m DMSA (V) scan in MCT patients with postoperative persistent hypercalcitoninemia in the positron emission tomography-computerized tomography (PET-CT) era. MATERIALS AND METHODS: A retrospective review of 53 patients with proven sporadic MCT, who presented to our institution over a period 28 years from 1985 to 2012, was performed. Patients with persistently elevated levels of serum calcitonin (>150 pg/ml) were initially evaluated by a DMSA scan if conventional imaging failed to localize any focus of disease. RESULTS AND CONCLUSIONS: Our study showed that the postoperative levels of serum calcitonin significantly correlated with the overall survival of our patients and can possibly serve as a good prognostic marker. Tc-99m DMSA (V) scans demonstrated a sensitivity of 75%, specificity of 56%, a positive predictive value of 50%, and a negative predictive value of 80% in detecting metastasis in postoperative persistent hypercalcitoninemia. Our study showed that Tc-99m DMSA (V) scanning is an affordable and a reasonably sensitive imaging agent for localization of recurrent/metastatic disease. PET-CT seems to be a useful complementary tool and needs to be kept in the armamentarium for diagnosis of recurrence especially in cases of discordance between Tc-99m DMSA (V) scan and the serum calcitonin levels. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4157187/ /pubmed/25210279 http://dx.doi.org/10.4103/0972-3919.136562 Text en Copyright: © Indian Journal of Nuclear Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Krishnamurthy, Arvind Kumar, Ramachandran Krishna Ravishankaran, Praveen Ramshankar, Vijayalaksmi Balkis Begum, Ahamed Sultan Rangarajan, Gomadam Kuppuswamy Exploring the role of technitium-99m dimercaptosuccinyl acid (V) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomography |
title | Exploring the role of technitium-99m dimercaptosuccinyl acid (V) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomography |
title_full | Exploring the role of technitium-99m dimercaptosuccinyl acid (V) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomography |
title_fullStr | Exploring the role of technitium-99m dimercaptosuccinyl acid (V) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomography |
title_full_unstemmed | Exploring the role of technitium-99m dimercaptosuccinyl acid (V) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomography |
title_short | Exploring the role of technitium-99m dimercaptosuccinyl acid (V) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomography |
title_sort | exploring the role of technitium-99m dimercaptosuccinyl acid (v) scan in medullary carcinoma thyroid patients with postoperative persistent hypercalcitoninemia in the era of positron emission tomography-computerized tomography |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157187/ https://www.ncbi.nlm.nih.gov/pubmed/25210279 http://dx.doi.org/10.4103/0972-3919.136562 |
work_keys_str_mv | AT krishnamurthyarvind exploringtheroleoftechnitium99mdimercaptosuccinylacidvscaninmedullarycarcinomathyroidpatientswithpostoperativepersistenthypercalcitoninemiaintheeraofpositronemissiontomographycomputerizedtomography AT kumarramachandrankrishna exploringtheroleoftechnitium99mdimercaptosuccinylacidvscaninmedullarycarcinomathyroidpatientswithpostoperativepersistenthypercalcitoninemiaintheeraofpositronemissiontomographycomputerizedtomography AT ravishankaranpraveen exploringtheroleoftechnitium99mdimercaptosuccinylacidvscaninmedullarycarcinomathyroidpatientswithpostoperativepersistenthypercalcitoninemiaintheeraofpositronemissiontomographycomputerizedtomography AT ramshankarvijayalaksmi exploringtheroleoftechnitium99mdimercaptosuccinylacidvscaninmedullarycarcinomathyroidpatientswithpostoperativepersistenthypercalcitoninemiaintheeraofpositronemissiontomographycomputerizedtomography AT balkisbegumahamedsultan exploringtheroleoftechnitium99mdimercaptosuccinylacidvscaninmedullarycarcinomathyroidpatientswithpostoperativepersistenthypercalcitoninemiaintheeraofpositronemissiontomographycomputerizedtomography AT rangarajangomadamkuppuswamy exploringtheroleoftechnitium99mdimercaptosuccinylacidvscaninmedullarycarcinomathyroidpatientswithpostoperativepersistenthypercalcitoninemiaintheeraofpositronemissiontomographycomputerizedtomography |